Investors
The telehealth business covers gaps in our healthcare system for patients interested in wellness products. The explosion of wellness products that include GLP-1s, Peptides, and Hormone Replacement represent a large market opportunity. Early cancer screening represents a huge market dominated by a group of testing companies using invasive techniques to make diagnoses. Our non-invasive tests with a single definitive biomarker have the potential to disrupt the multibillion dollar early cancer testing business.
Investors
NexTel Medical (OTCID: MAJI)
Revolutionizing Wellness & Early Detection Through Exosomal Innovation
NexTel Medical is innovating new products developed from its core exosomal technology to enhance its product offering for hard to access wellness products that require physician oversight and a prescription.
The company has 3 core business units:
- Telehealth
- Wellness Products
- Early Cancer Screening
Get Investor Updates
Latest News
March 11, 2026
NexTel Medical Announces Corporate Updates and Strategic Growth Initiatives
View Press Release → VIEW ALL PRESS RELEASESFebruary 27, 2026
NexTel Medical to Showcase Its Platform at NanoTech Conference 2026 and Provide Corporate Update
View Press Release →February 10, 2026
NexTel Medical Advances Manufacturing and Regulatory Roadmap with Consistency Results
View Press Release →Presentation
Early Cancer Testing Deck
Overview of NexTel Medical’s early cancer detection technology and market opportunity.
View Presentation →Press Releases
Latest company announcements and updates.
Stock Data
Current market performance and trading details.
Filings
Official disclosures and regulatory documents.
Presentations
Investor decks and company strategy insights.
Investor Presentation
Access our latest corporate presentation outlining strategy, growth opportunities, and key investment highlights.
Download PresentationPress Releases
Exousia Expands Oncology Platform
Advancing multi-cancer detection technologies and expanding strategic partnerships.
Nextel Medical Advances Telehealth Integration
Enhancing patient access through scalable telehealth infrastructure.
Maxasome Product Line Expansion Announced
Introducing next-generation exosomal wellness formulations.
Financial Filings
Access NexTel Medical’s latest financial filings, disclosures, and stock information directly through OTC Markets.
View Financial Filings →